![]() |
JOURNAL TOOLS |
Publishing options |
eTOC |
To subscribe |
Submit an article |
Recommend to your librarian |
ARTICLE TOOLS |
Reprints |
Permissions |
Share |


YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
THERAPEUTIC HOTLINE
Giornale Italiano di Dermatologia e Venereologia 2011 June;146(3):211-24
Copyright © 2011 EDIZIONI MINERVA MEDICA
language: English
New and innovative interventions in the management of pemphigus
Frydman A. S. 1, Fairley J. A. 1, 2 ✉
1 Department of Dermatology, The University of Iowa, IA, USA; 2 VA Medical Center, Iowa City, IA, USA
Pemphigus is a rare autoimmune blistering disease usually treated with systemic glucocorticoids with adjuvant immunosuppressants or anti-inflammatories. However significant morbidity and mortality is associated with these treatments. This review discusses conventional therapeutic options, as well as new and emerging therapies that may be safer alternatives to broad-based immunosuppression.